Iowa City, IA, United States of America

Nukhet Aykin-Burns


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Nukhet Aykin-Burns

Introduction

Nukhet Aykin-Burns is a prominent inventor based in Iowa City, IA, known for her significant contributions to cancer treatment research. She has developed innovative methods and compositions aimed at enhancing the efficacy of cancer therapies. With one patent to her name, her work focuses on increasing reactive oxygen species levels in cancer cell mitochondria.

Latest Patents

Her patent, titled "Compositions and methods of treating cancer," provides groundbreaking approaches to combat cancer. The invention involves an agent that increases reactive oxygen species (ROS) levels in cancer cell mitochondria, referred to as an XTPP agent, along with an inhibitor of hydroperoxide metabolism and a pharmaceutically acceptable diluent or carrier. This innovative method holds promise for improving cancer treatment outcomes.

Career Highlights

Nukhet has had a distinguished career, working with esteemed institutions such as the University of Iowa Research Foundation and the University of Michigan. Her research has significantly advanced the understanding of cancer treatment methodologies, showcasing her dedication to improving patient care.

Collaborations

Throughout her career, Nukhet has collaborated with notable colleagues, including Douglas R. Spitz, Jr. and Michael K. Schultz. These partnerships have further enriched her research and contributed to the development of her innovative cancer treatment methods.

Conclusion

Nukhet Aykin-Burns is a trailblazer in the field of cancer research, with her innovative patent offering new hope for effective cancer treatments. Her work exemplifies the impact of dedicated research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…